Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.

Schilling WHK. et al, (2024), PLoS Med, 21

A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults.

Hanboonkunupakarn B. et al, (2024), NPJ Vaccines, 9

Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)

Wongnak P. et al, (2024)

SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART)

Maitland K. et al, (2024)

Understanding patient and family experiences of critical care in Bangladesh and India: What are the priority actions to promote person-centred care?

Inglis R. et al, (2024), PLOS Glob Public Health, 4

Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).

Jittamala P. et al, (2023), J Infect Dis, 228, 1318 - 1325

The feasibility of novel point-of-care diagnostics for febrile illnesses at health centres in Southeast Asia: a mixed-methods study.

Adella FJ. et al, (2023), Trans R Soc Trop Med Hyg, 117, 788 - 796

Intestinal injury and the gut microbiota in patients with Plasmodium falciparum malaria.

Sriboonvorakul N. et al, (2023), PLoS Pathog, 19

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies.

Nguyen TD. et al, (2023), Nat Commun, 14

Determinants of Implementation of a Critical Care Registry in Asia: Lessons From a Qualitative Study.

Tolppa T. et al, (2023), J Med Internet Res, 25

Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV).

Schilling WHK. et al, (2023), Elife, 12

WHO should accelerate, not stall, rectal artesunate deployment for pre-referral treatment of severe malaria.

Peto TJ. et al, (2023), Trans R Soc Trop Med Hyg

Mixed methods study protocol for combining stakeholder-led rapid evaluation with near real-time continuous registry data to facilitate evaluations of quality of care in intensive care units.

Collaboration for Research, Implementation and Training in Critical Care in Asia and Africa (CCAA) None. et al, (2023), Wellcome Open Res, 8

Mixed methods study protocol for combining stakeholder-led rapid evaluation with near real-time continuous registry data to facilitate evaluations of quality of care in intensive care units

The Collaboration for Research, Implementation and Training in Critical Care in Asia and Africa (CCAA) None. et al, (2023)

Mixed methods study protocol for combining stakeholder-led rapid evaluation with near real-time continuous registry data to facilitate evaluations of quality of care in intensive care units

The Collaboration for Research, Implementation and Training in Critical Care in Asia and Africa (CCAA) None. et al, (2023)

Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples.

MalariaGEN None. et al, (2023), Wellcome Open Res, 8

Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples.

MalariaGEN None. et al, (2023), Wellcome open research, 8

SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART).

Maitland K. et al, (2023), Wellcome Open Res, 8

Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial

Wamae K. et al, (2022), Wellcome Open Research, 7, 95 - 95

MORU Tropical Health Network annual report 2021

Day N. et al, (2022)

Load More

Include forthcoming?